Stocktoria
Disc Medicine, Inc. IRON
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-08-12
Chart by TradingView
3/9
Piotroski F — financial health
13.8
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$236.0M | -$129.7M | -$91.1M | -$47.5M | -$30.9M |
| Net income | -$212.2M | -$109.4M | -$76.4M | -$46.8M | -$36.0M |
| Operating cash flow | -$180.4M | -$93.9M | -$73.5M | -$42.3M | -$27.5M |
| Free cash flow | -$181.3M | -$94.4M | -$73.6M | -$42.4M | -$27.6M |
| Total assets | $806.9M | $496.8M | $368.0M | $200.2M | $92.4M |
| Total liabilities | $67.1M | $53.2M | $22.9M | $23.6M | $14.8M |
| Shareholders' equity | $739.8M | $443.6M | $345.1M | $176.6M | -$64.2M |
| Ratios | |||||
| Return on assets | -26.3% | -22.0% | -20.8% | -23.4% | -38.9% |
| Return on equity | -28.7% | -24.7% | -22.1% | -26.5% | 56.0% |
| Debt / equity | 0.04× | 0.06× | 0.00× | — | — |
| Current ratio | 21.94 | 21.17 | 17.06 | 8.79 | 6.74 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 31,820 | $2.0M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 13.8 (safe)
- Working capital / assets 0.951
- Retained earnings / assets -0.632
- EBIT / assets -0.293
- Equity / liabilities 11.033
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001816736 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.